Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.91B |
| 2 |
Nasdaq
NDAQ
|
+$1.64B |
| 3 |
Wells Fargo
WFC
|
+$1.1B |
| 4 |
Edwards Lifesciences
EW
|
+$1.06B |
| 5 |
Gilead Sciences
GILD
|
+$890M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$1.86B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
HCA Healthcare
HCA
|
+$1.36B |
| 5 |
JPMorgan Chase
JPM
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.22% |
| 2 | Healthcare | 19.61% |
| 3 | Financials | 13.96% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Atour Lifestyle Holdings
ATAT
$4.73B
| $1.25M | ﹤0.01% |
+48,228
| New | +$896K |
|
1577
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
| $1.24M | ﹤0.01% |
6,197
| – | – |
|
1578
Aecom
ACM
$9.62B
| $1.24M | ﹤0.01% |
11,999
+546
| +5% | +$51.3K |
|
|
TSVT
1579
DELISTED
2seventy bio
TSVT
| $1.24M | ﹤0.01% |
262,040
+21,673
| +9% | +$97.7K |
|
1580
Iovance Biotherapeutics
IOVA
$2B
| $1.22M | ﹤0.01% |
129,482
+12,064
| +10% | +$114K |
|
1581
Altimmune
ALT
$591M
| $1.21M | ﹤0.01% |
197,232
+42,553
| +28% | +$288K |
|
1582
Pan American Silver
PAAS
$20.2B
| $1.21M | ﹤0.01% |
57,677
+26,960
| +88% | +$568K |
|
1583
Arrowhead Research
ARWR
$12.7B
| $1.2M | ﹤0.01% |
61,904
+886
| +1% | +$21.6K |
|
1584
Kiniksa Pharmaceuticals
KNSA
$6.01B
| $1.19M | ﹤0.01% |
+47,717
| New | +$1.16M |
|
|
CPRX
1585
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.18M | ﹤0.01% |
+59,584
| New | +$1.1M |
|
1586
J.M. Smucker
SJM
$12.7B
| $1.18M | ﹤0.01% |
9,769
+920
| +10% | +$108K |
|
1587
Albemarle
ALB
$14.2B
| $1.18M | ﹤0.01% |
+12,422
| New | +$1.1M |
|
|
MRSN
1588
DELISTED
Mersana Therapeutics
MRSN
| $1.17M | ﹤0.01% |
24,732
+3,417
| +16% | +$151K |
|
1589
Lamb Weston
LW
$7.31B
| $1.15M | ﹤0.01% |
17,822
-4,673
| -21% | -$309K |
|
1590
Lexicon Pharmaceuticals
LXRX
$1.09B
| $1.15M | ﹤0.01% |
732,747
-5,881
| -0.8% | -$10.5K |
|
1591
Monte Rosa Therapeutics
GLUE
$1.34B
| $1.15M | ﹤0.01% |
217,001
+50,330
| +30% | +$254K |
|
1592
Kyverna Therapeutics
KYTX
$464M
| $1.15M | ﹤0.01% |
235,123
-478,277
| -67% | -$3.69M |
|
1593
Steris
STE
$22.3B
| $1.15M | ﹤0.01% |
4,726
-544
| -10% | -$127K |
|
1594
Emergent Biosolutions
EBS
$391M
| $1.14M | ﹤0.01% |
136,289
+22,295
| +20% | +$203K |
|
1595
Strategy Inc
MSTR
$35.2B
| $1.13M | ﹤0.01% |
6,727
+497
| +8% | +$71.1K |
|
|
SWTX
1596
DELISTED
SpringWorks Therapeutics
SWTX
| $1.12M | ﹤0.01% |
34,994
+1,853
| +6% | +$69.2K |
|
1597
Tango Therapeutics
TNGX
$4.72B
| $1.1M | ﹤0.01% |
143,207
-6,570
| -4% | -$62.7K |
|
1598
Graham Corp
GHM
$1.24B
| $1.1M | ﹤0.01% |
+37,265
| New | +$1.11M |
|
|
PARA
1599
DELISTED
Paramount Global Class B
PARA
| $1.09M | ﹤0.01% |
102,406
-20,361
| -17% | -$221K |
|
|
ITOS
1600
DELISTED
iTeos Therapeutics
ITOS
| $1.08M | ﹤0.01% |
105,769
+18,255
| +21% | +$278K |
|
Similar funds
Wellington Management Group's Q3 2024 Portfolio in Review
As of Q3 2024, Wellington Management Group held 2,061 positions worth $571B, up 1.9% from $560B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Wellington Management Group withdrew a net $23.9B in Q3 2024, closing 151 positions and reducing 894 holdings. Its most notable exit was TE Connectivity, an estimated $895M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in Eversource Energy worth $809M.
- Wellington Management Group's largest Q3 2024 buy was Eversource Energy: 11,885,124 shares worth $809M.
- Wellington Management Group added most to Broadcom in Q3 2024, an estimated $1.91B increase.
- Wellington Management Group's biggest Q3 2024 reduction was EOG Resources, cutting an estimated $1.86B.
- Wellington Management Group fully exited TE Connectivity in Q3 2024, selling an estimated $895M.
- Wellington Management Group's ten largest holdings make up 23% of its $571B portfolio in Q3 2024.
- Wellington Management Group opened 193 new positions and closed 151 in Q3 2024.
- Wellington Management Group's portfolio value rose 1.9% quarter-over-quarter to $571B.
Based on Wellington Management Group's 13F filing for Q3 2024, filed 14 Nov 2024.